Rapamycin - Effects on Alzheimer's and Cognitive Health | MicrobiomeTrials← Back to trialsNCT04629495
Rapamycin - Effects on Alzheimer's and Cognitive Health
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2021-08-11Est. Completion: 2026-03-05
Enrollment target: 40 participants Locations- Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, San Antonio, Texas, United States
Other microbiome trials you might be interested in
Alzheimer Disease
The purpose of this research study is to evaluate a new radioactive compound used in positron emission tomography (PET) …
St Louis, United StatesCompleted Jan 2027
Mild Cognitive Impairment (MCI)
Cognitive reserve refers to the brain's ability to maintain cognitive performance despite age-related changes or neuropa…
Austin, United StatesEst. completion Feb 1, 2028
Nocturia
Overactive bladder (OAB) is a syndrome with urgency as the main symptom, usually accompanied by frequent urination, noct…
Jinan, ChinaEst. completion Jun 10, 2027